Obesity, Glucose Intolerance and Diabetes and Their Links to Cardiovascular Disease. Implications for Laboratory Medicine (Q34543079)

2 August 2017

1 reference

title

Obesity, glucose intolerance and diabetes and their links to cardiovascular disease. Implications for laboratory medicine (English)

1 reference

2 August 2017

Obesity, Glucose Intolerance and Diabetes and Their Links to Cardiovascular Disease. Implications for Laboratory Medicine (English)

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

28 March 2024

main subject

obesity

0 references

cardiovascular disease

1 reference

1 reference

Marek H. Dominiczak

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14598880

28 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14598880

28 March 2024

publication date

1 September 2003

1 reference

full work available at URL

2 August 2017

https://www.degruyter.com/document/doi/10.1515/CCLM.2003.194/pdf

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Clinical Chemistry and Laboratory Medicine

28 March 2024

published in

1 reference

2 August 2017

41

1 reference

2 August 2017

9

1 reference

2 August 2017

1266-1278

1 reference

The double puzzle of diabetes

2 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Diabetes mellitus and genetically programmed defects in beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Cardiovascular disease in type 2 diabetes mellitus: current management guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Global and societal implications of the diabetes epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Acquired right coronary artery fistula draining to the right ventricle: angiographic documentation of first appearance following reperfusion after acute myocardial infarction, with subsequent spontaneous closure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Insulin Resistant States and Insulin Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

The disease burden associated with overweight and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Hyperinsulinemia. A link between hypertension obesity and glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Components of the "metabolic syndrome" and incidence of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Management of dyslipidemia in children and adolescents with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Redefining type 2 diabetes: 'diabesity' or 'obesity dependent diabetes mellitus'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Diabesity: An Inflammatory Metabolic Condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Diet and risk of coronary heart disease and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Advanced protein glycosylation in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Carbonyl Stress and Diabetic Complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Oxidative stress in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Insulin signalling and the regulation of glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

An adipocentric view of signaling and intracellular trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Glucose-stimulated signaling pathways in biphasic insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Defective STAT signaling by the leptin receptor in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Transient increase in obese gene expression after food intake or insulin administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Adiponectin and development of type 2 diabetes in the Pima Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Relationship between lipoprotein levels and in vivo insulin action in normal young white men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Risk factors for coronary disease: the time for a paradigm shift?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Body mass index, diabetes, and C-reactive protein among U.S. adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Inflammation, the acute phase response and atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Challenges in optimal metabolic control of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Haemoglobin A1c – A Marker for Complications of Type 2 Diabetes: The Experience from the UK Prospective Diabetes Study (UKPDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Dyslipidemia in Patients with Type 2 Diabetes. Relationships between Lipids, Kidney Disease and Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Clinical Impact of the New Criteria for the Diagnosis of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

The Effect of the New ADA and WHO Guidelines on the Number of Diagnosed Cases of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Glycated hemoglobin standardization--National Glycohemoglobin Standardization Program (NGSP) perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Haemoglobin A1c: Analysis and Standardisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Point-of-Care Testing in Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Heterogeneity of the association between plasma homocysteine and atherothrombotic disease: insights from studies of vascular structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.194

Cardiovascular complications of diabetes mellitus: what we know and what we need to know about their prevention

21 January 2018

4

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

The genetics of type 2 diabetes

28 March 2024

11

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

28 March 2024

17

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

28 March 2024

The metabolic syndrome

22

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

28 March 2024

41

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes

28 March 2024

45

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells

28 March 2024

54

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Tumour necrosis factor-alpha exerts dual effects on human adipose leptin synthesis and release

28 March 2024

57

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Regulation of leptin production in cultured mature white adipocytes

28 March 2024

59

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Hyperlipidaemia and cardiovascular disease

28 March 2024

67

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.

28 March 2024

69

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

28 March 2024

70

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins

28 March 2024

72

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling

28 March 2024

74

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

28 March 2024

80

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

28 March 2024

89

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

28 March 2024

90

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study

28 March 2024

95

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

28 March 2024

99

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

28 March 2024

108

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

28 March 2024

109

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Renoprotection in diabetes: genetic and non-genetic risk factors and treatment

28 March 2024

121

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM

28 March 2024

122

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Evaluating novel cardiovascular risk factors: can we better predict heart attacks?

28 March 2024

123

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress, and fibrinogen

28 March 2024

124

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies

28 March 2024

125

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

Association of Fibrinogen With Cardiovascular Risk Factors and Cardiovascular Disease in the Framingham Offspring Population

28 March 2024

126

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.194

28 March 2024

Identifiers

1 reference

2 August 2017

1 reference